Athira Pharma Inc.

Athira Pharma Inc. (LONA) is a biopharmaceutical company focused on developing novel therapeutics for neurological diseases. The company is dedicated to improving the lives of individuals suffering from conditions such as Alzheimer's disease and other neurodegenerative disorders. Athira Pharma's research and development efforts center around small molecules designed to activate neurotrophic factors, which are essential for neuronal health and survival. By targeting these pathways, the company aims to address the underlying causes of cognitive decline and neuroinflammation. Athira Pharma operates within the biotechnology sector, striving to translate innovative science into meaningful treatments for patients with unmet medical needs in the field of neurological health. Their commitment lies in advancing potential therapies through rigorous clinical trials and scientific exploration, contributing to the evolving landscape of neurodegenerative disease treatment.